Darolutamide news

All news on Darolutamide (also known as Nubeqa): plants, production capacities, investments and involved companies in Europe.

21 July 2025
EU Approves Bayer's Nubeqa for Advanced Prostate Cancer
EU approves darolutamide with ADT for mHSPC, based on ARANOTE trial. Offers treatment flexibility with or without chemotherapy, enhancing patient care.

Who will be producing Darolutamide in the future?

Find out with chemXplore Analytics